☆ 4.7 Article

COVID-19 Vaccination in People Living with HIV (PLWH) in China: A Cross Sectional Study of Vaccine Hesitancy, Safety, and Immunogenicity

VACCINES (2021)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Immunology

Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults

Ritthideach Yorsaeng et al.

Summary: The immune response after the AZD1222 booster in individuals who received the two-dose CoronaVac vaccine was found to be limited, with lower neutralizing activity against the wild type and variants. However, the AZD1222 booster significantly enhanced the immune response, resulting in higher antibody levels and neutralizing activity.

VACCINE (2022)

添加到收藏夹

Article Immunology

The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living With Human Immunodeficiency Virus (HIV)

Bezawit A. Woldemeskel et al.

Summary: Past studies have shown that some vaccines do not elicit optimal responses in individuals living with HIV. However, this study demonstrates that the BNT162b2 vaccine induces robust immune responses in these patients comparable to those in healthy donors.

CLINICAL INFECTIOUS DISEASES (2022)

添加到收藏夹

Review Virology

HIV/SARS-CoV-2 coinfection: A global perspective

Osman N. Kanwugu et al.

Summary: This review provides an overview of SARS-CoV-2 infection in PLWH, discussing whether HIV-infected individuals are at increased risk of COVID-19 and severe disease, as well as exploring the potential protective effects of antiretroviral therapy or HIV-related immunosuppression.

JOURNAL OF MEDICAL VIROLOGY (2021)

添加到收藏夹

Article Virology

COVID-19 in people living with HIV: Clinical implications of dynamics of the immune response to SARS-CoV-2

Annalisa Mondi et al.

Summary: The study found that there was no increased risk and severity of COVID-19 in people living with HIV, although some patients showed immune abnormalities. Further large-scale studies are needed to better understand the impact of HIV infection on COVID-19 in terms of pathogenesis and treatment.

JOURNAL OF MEDICAL VIROLOGY (2021)

添加到收藏夹

Article Infectious Diseases

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial

Shengli Xia et al.

Summary: The inactivated SARS-CoV-2 vaccine, BBIBP-CorV, demonstrated safety and immunogenicity in two age groups. Humoral responses against SARS-CoV-2 were induced in all vaccine recipients by day 42. A two-dose immunisation with 4 mu g vaccine on days 0 and 21 or days 0 and 28 achieved higher neutralising antibody titres compared to other dosing schedules.

LANCET INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Infectious Diseases

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Yanjun Zhang et al.

Summary: This study investigated the safety, tolerability, and immunogenicity of the COVID-19 vaccine candidate CoronaVac, and found that the 3 μg dose showed higher seroconversion rates in the phase 2 trial.

LANCET INFECTIOUS DISEASES (2021)

添加到收藏夹

Letter Immunology

Residual viremia in HIV-infected patients who continue a two-drug or switch to a three-drug integrase strand transfer inhibitor based regimen

Nicola Gianotti et al.

Summary: The study found that switching from a two-drug regimen based on dolutegravir and a reverse transcriptase inhibitor to a single-tablet regimen of cobicistat, elvitregravir, emtricitabine, and tenofovir alafenamide did not reduce residual viremia burden at both week 48 and week 96. The immunological changes and safety profile of the two regimens were similar throughout the 96-week trial.

AIDS (2021)

添加到收藏夹

Article Immunology

Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data

Xueying Yang et al.

Summary: The study using N3C data in the US found that individuals with HIV infection have higher odds of COVID-19 death and hospitalisation, but lower odds of mild or moderate COVID-19. Factors such as older age, male gender, and specific racial/ethnic groups may exacerbate the risk of adverse COVID-19 outcomes among people with HIV.

LANCET HIV (2021)

添加到收藏夹

Article Immunology

Severe Acute Respiratory Syndrome Coronavirus 2: Vaccine Hesitancy Among Underrepresented Racial and Ethnic Groups With HIV in Miami, Florida

Deborah L. Jones et al.

Summary: This study investigated SARS-CoV-2 vaccine hesitancy among underrepresented ethnoracial groups with HIV, revealing prevalent medical mistrust, vaccine hesitancy, and negative sentiments about the vaccines, particularly among Black non-Latinx individuals. Targeted strategies are necessary to increase vaccine uptake in this population.

OPEN FORUM INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Immunology

COVID-19 Vaccination Willingness among Chinese Adults under the Free Vaccination Policy

Rugang Liu et al.

Summary: China's free COVID-19 vaccination policy significantly increased vaccination willingness rate, with concerns about safety and side effects being primary reasons for hesitancy. Age, medical insurance, and vaccine safety were important determinants for both paid and free vaccine, while income, occupation, and vaccine effectiveness were specifically important for the free vaccine. Recommendations include targeting older individuals without medical insurance for intervention, and focusing on high-income groups and professional workers to improve vaccination willingness rate. Strengthening nationwide education and communication on vaccine safety and effectiveness is also advised for policymakers.

VACCINES (2021)

添加到收藏夹

Article Immunology

COVID-19 Vaccine Hesitancy among French People Living with HIV

Alexandre Vallee et al.

Summary: The study revealed that nearly one third of people living with HIV were hesitant towards the COVID-19 vaccine, with concerns about their health, the requirement of vaccination, and their chronic disease status being the main factors influencing acceptance. Conversely, general vaccine refusal, concerns about side effects, and belief in existing immunity were the main factors driving vaccine hesitancy.

VACCINES (2021)

添加到收藏夹

Letter Immunology

An updated meta-analysis on the association between HIV infection and COVID-19 mortality

Yadong Wang et al.

AIDS (2021)

添加到收藏夹

Article Immunology

COVID-19 Vaccine Hesitancy Among PLWH in South India: Implications for Vaccination Campaigns

Maria L. Ekstrand et al.

Summary: A study conducted in India found that over one-third of people living with HIV exhibited vaccine hesitancy, citing concerns about safety, efficacy, and trust in information sources. To increase vaccination rates, efforts may benefit from leveraging trusted sources to provide clear information and emphasize the importance of vaccines in preventing severe disease and reducing transmission.

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2021)

添加到收藏夹

Article Immunology

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial

Shabir A. Madhi et al.

Summary: This study aimed to assess the safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine in people with HIV and HIV-negative individuals. The vaccine showed favorable safety and immunogenicity in people with HIV, including heightened immunogenicity in SARS-CoV-2 baseline-seropositive participants.

LANCET HIV (2021)

添加到收藏夹

Article Health Care Sciences & Services

Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications

Elise Paul et al.

Summary: This study identified predictors of negative attitudes towards vaccines and unwillingness to receive a COVID-19 vaccine among UK adults, with low-income groups, those who did not receive a flu vaccine last year, poor adherence to COVID-19 guidelines, female gender, and living with children being the most significant predictors of vaccine refusal. High levels of mistrust in vaccine benefit and concerns about future side effects were the most important determinants of vaccine uncertainty and unwillingness to vaccinate against COVID-19.

LANCET REGIONAL HEALTH-EUROPE (2021)

添加到收藏夹

Review Immunology

The interplay between HIV and COVID-19: summary of the data and responses to date

Lillian B. Brown et al.

Summary: Current evidence does not suggest that people living with HIV are at significantly higher risk of contracting SARS-CoV-2, but the prevalence of comorbidities associated with COVID-19 severity among PLWH remains a pressing issue. The COVID-19 epidemic has led to decreased access to HIV prevention services and testing, as well as worsened HIV treatment access and virologic control, potentially exacerbating the HIV epidemic.

CURRENT OPINION IN HIV AND AIDS (2021)

添加到收藏夹

Article Immunology

Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort

Pilar Vizcarra et al.

LANCET HIV (2020)

添加到收藏夹

Review Medicine, General & Internal

Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19) A Review

W. Joost Wiersinga et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

添加到收藏夹

Article Medicine, General & Internal

Attitudes Toward a Potential SARS-CoV-2 Vaccine A Survey of US Adults

Kimberly A. Fisher et al.

ANNALS OF INTERNAL MEDICINE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19

Naoki Kaneko et al.

CELL (2020)

添加到收藏夹

Article Medicine, General & Internal

Factors Associated With US Adults' Likelihood of Accepting COVID-19 Vaccination

Sarah Kreps et al.

JAMA NETWORK OPEN (2020)

添加到收藏夹

Article Psychology, Multidisciplinary

A Proactive Approach for Managing COVID-19: The Importance of Understanding the Motivational Roots of Vaccination Hesitancy for SARS-CoV2

Steven Taylor et al.

FRONTIERS IN PSYCHOLOGY (2020)

添加到收藏夹

Review Immunology

Germinal centers B-cell reaction and T follicular helper cells in response to HIV-1 infection

Raphael Jeger-Madiot et al.

CURRENT OPINION IN HIV AND AIDS (2019)

添加到收藏夹

Article Virology

High prevalence of syphilis, HBV, and HCV co-infection, and low rate of effective vaccination against hepatitis B in HIV-infected patients in West China hospital

Tingting Yang et al.

JOURNAL OF MEDICAL VIROLOGY (2018)

添加到收藏夹

Article Immunology

Association of provider recommendation and offer and influenza vaccination among adults aged ≥18 years - United States

Peng-jun Lu et al.

VACCINE (2018)

添加到收藏夹

Article Multidisciplinary Sciences

HIV-positive gay men's knowledge and perceptions of Human Papillomavirus (HPV) and HPV vaccination: A qualitative study

Daniel Grace et al.

PLOS ONE (2018)

添加到收藏夹

Article Infectious Diseases

Predictors for and coverage of influenza vaccination among HIV-positive patients: a cross-sectional survey

N. Harrison et al.

HIV MEDICINE (2017)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Association of time since pneumococcal polysaccharide vaccine receipt and CD4 count with antibody response to the 13-valent pneumococcal conjugate vaccine in HIV-infected adults

Alexandria E. -B. Rossheim et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)

添加到收藏夹

Article Virology

Comparison of the effects of acute influenza infection and influenza vaccination on HIV viral load and CD4 cell counts

DJ Skiest et al.

JOURNAL OF CLINICAL VIROLOGY (2003)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.